Mylan expands valsartan recall to all unexpired lots in US

Mylan Pharmaceuticals expanded its voluntary drug recall to include all unexpired valsartan-containing products in the U.S., the FDA announced Dec. 4. The action joins a host of other recalls over the last few months related to carcinogenic impurities being found in angiotensin II receptor blockers (ARBs), a class of medications used to treat hypertension and heart failure.

Patient information incomplete in EHR-based imaging orders compared to clinician notes

Imaging orders sent via electronic health records (EHRs) have less complete—and consequently less reliable—patient information than those found in physician notes on the same patient in the same EHR, according to research published online Dec. 5 in the Journal of the American Medical Informatics Association.